Portfolio

Fund Capital commitment from BGF (million) Fund size (million) % BGF Investment date Sector focus Stage of investment
Fortino Capital Growth PE I € 20 € 242 8,3% 20/11/2019 ICT & Technology Late stage venture
Smartfin Capital II € 25 € 239 10,5% 20/11/2019 ICT & Technology Late stage venture
Sofindev V € 20 € 170 11,8% 23/12/2019 Generalistic Growth & Buy-out
Gilde Healthcare V € 15 € 416 3,6% 17/03/2020 Life sciences Late stage venture
Forbion Growth Opportunities Fund I € 20 € 360 5,6% 01/07/2020 Life sciences Late stage venture
Andera Expansion III € 20 € 250 8,0% 25/11/2021 Generalistic Growth & Buy-out
Kurma Growth Opportunities € 16 € 167 9,6% 14/02/2022 Life sciences Late stage venture
Apheon MidCap Buyout V € 25 € 800 3,1% 23/05/2022 Generalistic Growth & Buy-out
Forbion Growth Opportunities Fund II € 10 € 616 1,6% 31/05/2022 Life sciences Late stage venture
Fortino Capital Growth PE II € 20 € 327 6,1% 14/06/2022 ICT & Technology Late stage venture
Mentha Capital Fund VII € 8 € 265 2,8% 27/09/2022 Generalistic Growth & Buy-out
Sofindev VI € 15 € 250 6,0% 31/03/2023 Generalistic Growth & Buy-out
Smartfin Capital III € 10 € 207 4,4% 24/05/2023 ICT & Technology Late stage venture
EQT Health Economics III € 10 - - 28/12/2023 Life sciences Late stage venture
M80 Capital II € 15 € 120 (still in fundraising) 12,5% 29/01/2024 Generalistic Growth & Buy-out
Strada Partners I € 15 € 202 7,4% 15/03/2024 ICT & Technology Late stage venture
Junction Growth Investors € 15 - - 28/03/2024 ICT & Technology Late stage venture
Main Foundation II € 15 € 507 3,0% 28/03/2024 ICT & Technology Late stage venture
Vendis Capital IV € 15 - - 07/05/2024 Consumer Growth & Buy-out
TOTAL € 308 € 5188
Fortino Capital Growth PE I & II

Fortino invests in ambitious scale-ups and more mature business (SMEs) which are facing typical challenges regarding go-to-market, innovation and organizational design and talent management. Fortino supports CEOs and their management teams to scale internationally.

https://www.fortinocapital.com/


Smartfin Capital II & III

Smartfin provides replacement and expansion capital to European growth companies that display the potential for significant value creation in fast growing market segments. Smartfin combines financial, operational and entrepreneurial experience supporting its portfolio companies in their growth ambitions.

smartfinvc.com


Sofindev V & VI

Sofindev is an independent private equity firm investing in small and medium sized enterprises in Belgium since 1991. Sofindev invests in buyout and growth capital in profitable Belgian SME’s to support their growth strategy.

sofindev.com


Gilde Healthcare V

Gilde Healthcare V is a €416 million venture and growth capital fund and targets growth opportunities in healthcare sectors including digital health, medtech and therapeutics, both in Europe and North America.

https://gildehealthcare.com/nl/

Forbion Growth Opportunities I & II

Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform people’s lives. The fund approaches the market through three strategies and focuses on growth capital, pre-IPO financing and the support of undervalued assets.

https://forbion.com/en/

Andera Expansion III

Andera is a major player in private company investments in France, Belgium and internationally. Its teams manage over EUR 3,0 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion and Andera Croissance), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to its investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our teams, based on shared values.

www.anderapartners.com



Kurma Growth Opportunities

Kurma Partners is a prominent player in the life sciences field in Western Europe. With close to EUR 700 million of assets under management and more than 55 investments since its inception in 2009, this fund manager has developed a strong expertise in financing healthcare innovations, from pre-seed to growth stage. Kurma has built a unique network of partners with the best European academic research players, to transform their disruptive scientific discoveries into cutting-edge medicines or medical devices to diagnose and treat patients with severe diseases with high unmet medical need.

https://www.kurmapartners.com/

Apheon MidCap Buyout V

Apheon is a mid-market private equity investment company with EUR 2.5 billion of assets under management from select European institutional investors and families. Apheon is a disciplined, discreet and responsible value investor, which provides “patient and friendly capital” to entrepreneurs and managers who need capital, industrial know-how or technological solutions to accelerate the development of their companies. Apheon has offices in Brussels, Amsterdam, Paris, Munich, Milan and Madrid. Since its inception in 2005, Apheon has raised approximately €3.0 billion, invested in 34 companies.

apheon.com

Mentha Capital Fund VII

Mentha Capital is an independent private equity firm active in the lower end of the mid-market in the Netherlands, Belgium and Denmark. Through its funds the company invests in mid-sized and profitable companies with clear opportunities for growth along multiple avenues, such as organic growth, expansion in new markets and/or a buy-and-build approach. Mentha manages capital from a solid base of wealthy individuals, families and institutional investors with a long-term investment horizon. The entrepreneurial team of investment professionals, with strong financial and corporate business experience, likes to team up with management to jointly realize ambitious business plans.

https://mentha.eu/


EQT Health Economics III

EQT Life Sciences, formerly LSP, is one of Europe’s largest healthcare investors, targeting innovative life sciences and healthcare companies. With a dedicated team of experienced investment professionals, coming from backgrounds in medicine, science, and industry, EQT Life Sciences backs inventors who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek.

https://eqtgroup.com/

M80 Capital II

M80 Partners is a Belgian generalist private equity fund manager investing in high growth lower mid-cap SME’s in Benelux and France. The focus is on ambitious companies & entrepreneurs that embrace change and with whom the fund manager works closely to realize their full potential - often by making smart or better use of digital platforms. Its diverse international team of former entrepreneurs, ex- CEOs, private equity professionals and digital pioneers looks to inspire, challenge and support companies to generate meaningful value for their customers, employees, owners and investors.

www.m80partners.com

Strada Partners I

Strada Partners is a European growth-oriented investment firm founded by Bart Wouters and Matthias Vandepitte, who have a combined 25+ years of experience in private equity. The team’s track record includes investments across industries, focusing on software, tech-enabled service businesses and healthcare. Strada Partners builds a concentrated portfolio of investments that they can support over the longer term and provide with the necessary tools to compound growth on a pan-European level. Stada Partners provides patient capital, with impatience to succeed. We are not afraid of the road less travelled. The Fund usually invests tickets up to €25m.

https://strada-partners.com/


Junction Growth Investors


Junction Growth Investors is a Belgian specialist investor with a focus on impact-driven companies developing software and hardware solutions that “enable” the energy transition. The focus of the fund is on late-stage VC and growth companies with proven technology/services and commercial traction. They look mainly at clean energy production enabling technologies & energy efficiency technologies for building and renovation industries. The geographical focus is on companies with HQ in the Benelux, France and DACH-region. Junction has a strong and balanced team of former entrepreneurs and seasoned investment professionals, with proven track-record in internationally successful energy (tech) businesses.

junctiongrowthinvestors.com

Main Foundation II

Main Capital Partners a leading enterprise software investor active in Northwestern Europe and North America. Leveraging 20 years’ experience in B2B software investing and deep-sector knowledge, Main works closely with management teams in its portfolio to achieve sustainable growth and larger outstanding software groups. Its unique focus on enterprise software, local presence, its proven value creation framework and its efficient data-driven way of working make MCP a solid partner for software companies with international expansion ambitions.

https://main.nl/


Vendis Capital IV

Vendis Capital IV is a Belgium based specialist consumer industry private equity firm that invests in scale-up opportunities in attractive sub-sectors and niches within the European consumer sector. Vendis Capital partners with ambitious consumer-focused businesses, providing growth capital and strategic support to facilitate their international scaling, their channel as well as category extension through organic and buy-and-build growth. The firm’s investment approach emphasizes the development of high-quality companies across selective consumer sub-sectors, within Western Europe, with a specific focus on Belgium, the Netherlands, France, the DACH region and the Scandinavian countries.

https://www.vendiscapital.com/nl/

Top